4/A: Supernus Pharmaceuticals Executive Corrects Stock Option Reporting
SEC Filing
Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, files an amended Form 4 to correct the number of derivative securities beneficially owned following a transaction.
Summary
- Padmanabh P. Bhatt, a Senior VP at Supernus Pharmaceuticals, filed an amended Form 4 with the SEC.
- The amendment corrects an error in the original filing regarding the number of derivative securities (employee stock options) beneficially owned after a transaction on January 28, 2025.
- The original Form 4, filed on January 29, 2025, incorrectly reported the number of derivative securities beneficially owned as 9,477.
- The corrected filing shows the number of derivative securities beneficially owned following the transaction should have been 13,727.
- The correction relates to options granted on February 19, 2021, for 17,000 exercisable shares.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't indicate any significant positive or negative developments for the company, but transparency is generally viewed favorably.
Negatives
- The original Form 4 contained an error in reporting the number of derivative securities beneficially owned.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. Amendments are sometimes necessary to correct errors in the original filings.
Stakeholder Impact
- The correction of the filing ensures accurate information is available to shareholders and the public.
Key Dates
| Date | Description |
|---|---|
| 02/19/2021 | Mr. Bhatt was granted 17,000 exercisable shares. |
| 02/19/2022 | The option vested in four equal installments beginning on this date. |
| 01/28/2025 | Date of transaction where 700 employee stock options were exercised. |
| 01/29/2025 | Date of original Form 4 filing with incorrect information. |
| 02/05/2025 | Date of amended Form 4/A filing. |
| 02/19/2031 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.